Filing Details
- Accession Number:
- 0001209191-21-015496
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-01 20:54:05
- Reporting Period:
- 2021-02-25
- Accepted Time:
- 2021-03-01 20:54:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1733642 | San Pui Kwan | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Principal Acctg Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-01 | 1,389 | $10.86 | 4,621 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 1,125 | $11.02 | 5,746 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-01 | 833 | $9.04 | 6,579 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-01 | 1,530 | $68.08 | 5,049 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-03-01 | 1,817 | $68.89 | 3,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Acquisiton | 2021-02-25 | 16,640 | $0.00 | 16,640 | $65.87 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 1,389 | $0.00 | 1,389 | $10.86 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 1,125 | $0.00 | 1,125 | $11.02 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-03-01 | 833 | $0.00 | 833 | $9.04 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,640 | 2031-02-25 | No | 4 | A | Direct | |
| 13,897 | 2028-03-05 | No | 4 | M | Direct | |
| 24,750 | 2029-03-04 | No | 4 | M | Direct | |
| 25,834 | 2029-11-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $67.64 to $68.60 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $68.64 to $69.19 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The option was granted on February 25, 2021, and 25% of the total number of shares of common stock subject to the option vests on January 1, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date.
- Not applicable.
- As of March 1, 2021, and prior to this transaction, the exercised options were fully vested.
Billionaire Hedge Funds
